⏳ Fetching live dividend data...
Home › Calculator › IGMS Dividend Calculator 2026
IGM Biosciences, Inc. · NASDAQ
Price: $1.27 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IGMS → $128.07M in 10 years · $6,527,416.34/month
IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, including various cancers, infectious ailments, and autoimmune and inflammatory disorders. The company's most advanced experimental treatment is IGM-2323, a bispecific IgM antibody. This candidate is currently in Phase 2 clinical trials, evaluating its efficacy for patients diagnosed with relapsed or refractory B cell Non-Hodgkin's lymphoma (NHL). In addition to its lead program, IGM Biosciences maintains an active pipeline of other IgM antibodies. IGM-8444, an IgM antibody, is presently undergoing Phase 1 clinical trials for solid cancers. Another therapy in development, IGM-7354, is an anti-PD-L1 IgM antibody targeting both solid and hematologic malignancies. The company is also progressing IGM-2644, a bispecific T cell engaging IgM antibody designed to target CD38 and CD3 proteins, intended for individuals with multiple myeloma. Furthermore, IGM-2537, another bispecific T cell engaging IgM antibody, aims to target CD123 and CD3 proteins for potential use in acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. IGM Biosciences has a strategic collaboration and licensing arrangement with Genzyme Corporation. This partnership encompasses the generation, development, manufacturing, and commercialization of IgM antibodies. The company, initially founded in 1993 as Palingen, Inc., changed its name to IGM Biosciences, Inc. in 2010. Its corporate headquarters are located in Mountain View, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IGMS position with:
Real after-tax yield depends on where you live and how you hold IGMS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 157.48% | 154.68% | $15,748 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 133.86% | 131.06% | $13,386 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 125.98% | 123.18% | $12,598 / yr |
| 🇬🇧 UK ISA | 0% | 157.48% | 154.68% | $15,748 / yr |
| 🇬🇧 UK Taxable | 8.75% | 143.70% | 140.90% | $14,370 / yr |
| 🇨🇦 TFSA | 0% | 157.48% | 154.68% | $15,748 / yr |
| 🇨🇦 CA Taxable | 25% | 118.11% | 115.31% | $11,811 / yr |
| 🇦🇺 Super (pension) | 15% | 133.86% | 131.06% | $13,386 / yr |
| 🇦🇺 AU Taxable | 30% | 110.24% | 107.44% | $11,024 / yr |
| 🇩🇪 DE Taxable | 26.375% | 115.94% | 113.14% | $11,594 / yr |
| 🇫🇷 FR Taxable | 30% | 110.24% | 107.44% | $11,024 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IGMS pays quarterly — 4 times per year. Next ex-div: TBD.
How IGMS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IGMS sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| U-Tender | 2025-08-14 | 3,763,362 | $1.25 | $4.69M | ||
| U-Tender | 2025-08-14 | 9,886,217 | — | — | ||
| D-Return | 2025-08-14 | 2,964,843 | $1.25 | $3.70M | ||
| D-Return | 2025-08-14 | 7,199,325 | — | — | ||
| D-Return | 2025-08-14 | 667,666 | $0.01 | $6.7K | ||
| D-Return | 2025-08-14 | 2,000 | — | — | ||
| D-Return | 2025-08-14 | 12,712 | $1.25 | $15.9K | ||
| D-Return | 2025-08-14 | 5,044,295 | — | — | ||
| D-Return | 2025-08-14 | 10,400,564 | — | — | ||
| D-Return | 2025-08-14 | 5,044,295 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IGMS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
IGM Biosciences, Inc. (IGMS) is currently trading at $1.27, 99% below its 52-week high. The current dividend yield is 157.48% based on an annual payout of $2.00 per share.
IGM Biosciences, Inc. (IGMS) is a healthcare stock currently trading at $1.27 with a dividend yield of 157.48%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →